Long-term survival of ipilimumab-naive patients (pts) with advanced melanoma (MEL) treated with nivolumab (anti-PD-1, BMS-936558, ONO-4538) in a phase I trial.
F. Stephen Hodi
No relevant relationships to disclose
Mario Sznol
Consultant or Advisory Role - Amgen; Anaeropharma; Bristol-Myers Squibb; Genentech; MedImmune; Nektar; Symphogen
Harriet M. Kluger
No relevant relationships to disclose
David F. McDermott
Consultant or Advisory Role - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
Richard D. Carvajal
No relevant relationships to disclose
Donald P. Lawrence
No relevant relationships to disclose
Suzanne Louise Topalian
Consultant or Advisory Role - Bristol-Myers Squibb (U); Jounce Therapeutics; Sanofi
Research Funding - Bristol-Myers Squibb
Other Remuneration - Amplimmune (I); Bristol-Myers Squibb (I)
Michael B. Atkins
Consultant or Advisory Role - Bristol-Myers Squibb
Honoraria - Bristol-Myers Squibb
John D. Powderly
Employment or Leadership Position - Biologics Human Application Lab
Consultant or Advisory Role - Amplimmune; Bristol-Myers Squibb; Genentech; Merck
Honoraria - Bristol-Myers Squibb
Research Funding - Amplimmune; Bristol-Myers Squibb; Genentech; Merck
Other Remuneration - Bristol-Myers Squibb
William Howard Sharfman
No relevant relationships to disclose
Igor Puzanov
No relevant relationships to disclose
David C. Smith
Research Funding - Bristol-Myers Squibb
Philip D. Leming
No relevant relationships to disclose
Evan J. Lipson
No relevant relationships to disclose
Janis M. Taube
Consultant or Advisory Role - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
Robert Anders
Research Funding - Bristol-Myers Squibb
Christine E. Horak
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb
Georgia Kollia
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb
Ashok Kumar Gupta
Employment or Leadership Position - Bristol-Myers Squibb
Stock Ownership - Bristol-Myers Squibb
Jeffrey Alan Sosman
Consultant or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline
Honoraria - Amgen; GlaxoSmithKline
Research Funding - Bristol-Myers Squibb; GlaxoSmithKline; Novartis